Corium
Jeffrey Gaffey has over 20 years of experience in financial planning and analysis. Jeffrey is currently the VP and Head of FP&A at Corium, Inc. Prior to this, they served as the Head of FP&A at Apellis Pharmaceuticals and Executive Director of Financial Planning Analysis at Epizyme. Jeffrey also held roles such as Director of FP&A at Merrimack and Associate Director of FP&A at Synageva BioPharma Corp. Jeffrey has extensive experience in financial management, business partnering, and implementing financial systems and processes. Early in their career, they worked at Sanofi Genzyme, Vertex Pharmaceuticals, Bristol-Myers Squibb, RIGHTNOW TECHNOLOGIES, and STATE STREET CORPORATION, where they gained valuable experience in finance and accounting analysis, sales forecasting, and international equities.
Jeffrey Gaffey obtained a Bachelor of Science degree in Economics and Finance from Boston College, which they completed from 1996 to 2000.